AI assistant
Sending…
MEDIFAST INC — Director's Dealing 2017
Feb 21, 2017
33899_dirs_2017-02-21_64f5deff-b88b-49d2-91e6-8a0521a1f65c.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: MEDIFAST INC (MED)
CIK: 0000910329
Period of Report: 2017-02-16
Reporting Person: MACDONALD MICHAEL C (Director, Exec Chairman of the Board)
Non-Derivative Transactions
| Date | Security | Code | Shares | Price | A/D | Holdings After | Ownership |
|---|---|---|---|---|---|---|---|
| 2017-02-16 | Common Stock | A | 38000 | — | Acquired | 360488 | Direct |
| 2017-02-16 | Common Stock | A | 15620 | — | Acquired | 376108 | Direct |
| 2017-02-19 | Common Stock | F | 8000 | $45.07 | Disposed | 368108 | Direct |
Footnotes
F1: Represents shares issued to the reporting person under the 2012 Share Incentive Plan after pre-established performance -based conditions were satisfied for the 2016 performance period.
F2: This one time retention stock grant, which was issued to the reporting person under the 2012 Share Incentive Plan, will vest annually in equal installments over a period of three years, beginning on the first anniversary of the grant date.
More from MEDIFAST INC
Regulatory Filings
2026
May 26
Annual Report
2026
Apr 6
Director's Dealing
2026
Mar 27
Director's Dealing
2026
Mar 27
Director's Dealing
2026
Mar 27
Director's Dealing
2026
Mar 27
Major Shareholding Notification
2026
Mar 27
Major Shareholding Notification
2026
Mar 20
Regulatory Filings
2026
Mar 20
Annual Report
2026
Feb 17